Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
Z1PURMWefD7PmQZL
